EUVIMEDEUVIMED entdecken
Crossref

Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer

Nan Zhou, Yuan Yuan, Huijuan Lin, Jian Wang, Huan Lin, Hassan Ashktorab, Duane Smoot, Zhe Jin, Shutong Zhuang, Ying Qin

Anticancer Research · 2025-05 · 45 (5) · 1935-1951

DOI: 10.21873/anticanres.17571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 28.04.2025. Verfasst von Nan Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Early Growth Response Protein 1, Catechin, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. MicroRNAs (miRNAs) are key regulators of tumorigenesis. This study investigated the role of the miR-192/215-early growth response protein 1 (EGR1) axis in GC and explored its therapeutic implications. MATERIALS AND METHODS: Combinatorial molecular approaches including dual-luciferase reporter assays and western blot analyses were employed to authenticate EGR1 as a direct target of miR-192/215. Multi-modal data analysis incorporating The Cancer Genome Atlas datasets and our institutional cohort (n=56) was conducted to delineate EGR1 expression profiles across clinicopathological GC stages. Pharmacological modulation studies were implemented to characterize the dose- and time-dependent effects of epigallocatechin-3-gallate (EGCG) on the miR-192/215-EGR1 axis. RESULTS: EGR1 is a direct target of miR-192/215, with its expression negatively regulated by these miRNAs. Clinical analysis revealed significantly reduced EGR1 expression in tumors of early-stage GC (stage I) and cases with superficial invasion depth (T1) (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsEarly Growth Response Protein 1CatechinStomach NeoplasmsHumansGene Expression Regulation, NeoplasticCell Line, TumorFemaleMaleMiddle AgedCell ProliferationAged

Stichwörter der Autor:innen

EGR1Gastric cancerepigallocatechin gallatemiR-192miR-215

Substanzen

MicroRNAsepigallocatechin gallateEarly Growth Response Protein 1CatechinEGR1 protein, humanMIRN192 microRNA, human

Autor:innen und Institutionen

  • Guangxi University of Chinese Medicine, Nanning, P.R. China.
  • Department of Gastrointestinal Surgery, Shenzhen Second People's Hospital (First Affiliated Hospital of Shenzhen University), Shenzhen, P.R. China.
  • Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, P.R. China.
  • Department of Ultrasound, Guangdong Women and Children Hospital, Guangzhou, P.R. China.
  • Nuclear Medicine Department, Jiangxi Pingxiang People's Hospital, Pingxiang, P.R. China.
  • Department of Vascular Surgery, Shenzhen Second People's Hospital (First Affiliated Hospital of Shenzhen University), Shenzhen, P.R. China.

Zitieren

APA

Zhou, N., Yuan, Y., Lin, H., Wang, J., Lin, H., Ashktorab, H., Smoot, D., Jin, Z., Zhuang, S., & Qin, Y. (2025). Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer. Anticancer Research, 45(5), 1935-1951. https://doi.org/10.21873/anticanres.17571

Vancouver

Zhou N, Yuan Y, Lin H, Wang J, Lin H, Ashktorab H, et al. Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer. Anticancer Research. 2025;45(5):1935-1951. doi:10.21873/anticanres.17571

BibTeX
@article{Zhou2025,
  author = {Zhou, Nan and Yuan, Yuan and Lin, Huijuan and Wang, Jian and Lin, Huan and Ashktorab, Hassan and Smoot, Duane and Jin, Zhe and Zhuang, Shutong and Qin, Ying},
  title = {Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer},
  journal = {Anticancer Research},
  year = {2025},
  volume = {45},
  number = {5},
  pages = {1935--1951},
  doi = {10.21873/anticanres.17571}
}
Kostenlos starten →